Preparation of purine analogs as heat shock protein 90 (HSP90) inhibitors.

  • Kasibhatla S
  • Hong K
  • Zhang L
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Title compds. [I; A = H, halo, cyano, N2, amino, alkyl, guanidino, amidino, perhaloalkyl, OR3, SR3, etc.; Q = (substituted) alkyl, cycloalkyl, aralkyl, aryl, heteroaryl; X = S, SO, SO2; Y = H, COR2, SO2R2, CO2R2, (substituted) alkyl, alkenyl, alkynyl, aryl, aryloxyalkyl, alicyclyl, etc.; Z = H, halo, cyano, OR3, SR3, perhaloalkyl, (substituted) alkyl, alkenyl, alkynyl, aryl, alicyclyl, aralkyl, aryloxyalkyl, alkoxyalkyl, heterocyclyl, COR2, SO2R2, guanidino, amidino, etc.; R2 = (substituted) alkyl, heteroalkyl, cycloalkyl, heterocyclyl, heteroaryl, aryl; R3 = H, (substituted) alkyl, cycloalkyl, heteroalkyl, aryl, heterocyclyl, etc.], were prepd. Thus, 6-chloro-8-(2,5-dimethoxybenzyl)-N9-butylpurine (prepn. given) was heated in a sealed tube with aq. NH3 at 100° for 48 h to give 8 -(2,5-dimethoxybenzyl)-9-butyladenine. The latter showed HSP90 binding ability with IC50 = 10 μM. [on SciFinder(R)]

Cite

CITATION STYLE

APA

Kasibhatla, S. R., Hong, K., Zhang, L., Biamonte, M. A., Boehm, M. F., Shi, J., & Fan, Junhua. (2003, May 8). Preparation of purine analogs as heat shock protein 90 (HSP90) inhibitors. PCT Int. Appl. Conforma Therapeutics Corporation, USA .

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free